Will lessons from COVID-19 and TB vaccine rollout improve pandemic preparedness and health security?

Ode Uduu, Shobha Shukla, Bobby Ramakant *

TB high burden countries India and Nigeria both have had decades of experience in rolling out the TB vaccine. Both nations were successful (even if not ideal) in reaching out to a large part of their populations with COVID-19 vaccination. Are there any lessons that we can learn from this experience of rolling out vaccines against TB and COVID-19, which might pave the way for improving preparedness for the rollout of future vaccines?

We spoke with experts in both these nations - as a new TB vaccine, which is currently in Phase-3 study in India (and elsewhere too), if proven safe and effective, would need readiness and preparedness to ensure that it reaches everyone who needs it, timely. As promised by governments, only 32 months are left for India to end TB (by 2025) and 92 months are left for Nigeria and other countries globally to do so by 2030.

Century-old TB vaccine and still not 100% coverage in hard-hit nations

The only vaccine against TB, the 102 years old BCG (Bacille Calmette Guerin), has a protective effect against meningitis and disseminated TB in children. It does not prevent primary infection and does not prevent reactivation of latent pulmonary infection. It is hard to fathom that why for a disease that was the deadliest infectious disease in the world before COVID-19 hit us, why better vaccines to prevent and control TB are not around yet? More importantly, despite 102 years of BCG vaccine being around, its coverage is still not 100% in TB hard-hit nations like India and Nigeria - as per WHO data, BCG vaccine coverage in 2021 was 84% in India and 75% in Nigeria.

Science first: “While the neonatal BCG vaccination is partially effective in reducing the risk and severity of serious forms of TB, like miliary TB and TB meningitis in infants and young children, it is poorly protective against pulmonary disease in adolescents and adults. There is a critical need for new TB vaccines that are more effective than the existing BCG vaccine in preventing pulmonary as well as extra-pulmonary forms of TB in all age groups,” said Prof Surya Kant, scientific Chairperson of 77th National Conference of Tuberculosis and Chest Diseases held in Agra, India.

BCG vaccine is contraindicated in those with cell-mediated immune deficiency. While HIV infected, non-symptomatic infants should be immunized with BCG vaccine according to standard schedules, infants with clinical (symptomatic) AIDS should not receive it.

First BCG shot in 1921: Why did it take decades to scale up its rollout?

BCG vaccine was first administered in humans in 1921. Despite the crippling burden of TB, it took almost another half a century for governments to begin resolving issues, which marred its rollout in TB affected nations, including manufacturing and supply-chain related issues.

“In 1970s and early 1980s, supply of BCG vaccine was very erratic for a very long time. So, we did not have much vaccine stock. BCG immunization picked up only after mid-1980s,” said Dr Jacob John, Professor, Community Health department, Christian Medical College (CMC) Vellore, India. Vaccine shortage was so acute back then that “we had to import it from Denmark. Moreover, as it is not easy to maintain these doses, there was lot of wastage of the doses,” said Dr John.

“In those days not just BCG vaccine uptake was low, but all other vaccination rates were low too. Institutional delivery rate was also low. Institutional delivery rates began picking up in mid-1980s,” said Dr John. “BCG vaccination is now a part of institutional deliveries – when babies are born people know they have to give them vaccines, including BCG vaccine.”

Agrees Dr Shibu Vijayan, a noted public health crusader who currently serves as Medical Director (Global Health) at “Births that earlier happened at homes are now happening at medical facilities. The route of BCG vaccine is a health facility-based function. So, if the baby is not delivered in a medical facility, he/ she/ they may not get the vaccine.”

A similar situation thrives in Nigeria: The nurse in charge of primary health centre (PHC) Angwan Maikai, Keffi, Nasarawa State in Nigeria, said that, like other PHCs, mothers are informed of the various vaccines, including BCG, during antenatal care. The challenge comes for those who do not attend antenatal or delivery at health facilities.

When vaccine coverage is low, hesitancy is also low

“I do not think it was an issue of vaccine hesitancy in those times, but an issue of the reach of immunization services, including those for BCG,” said Dr Jacob John. “When your vaccine coverage is quite low, then issue of vaccine hesitancy is also low.”

A TB case worker with APIN Public Health Initiative, Mercy Depuun noted that the uptake of vaccines in Nigeria has been generally low because of hesitancy from the public, and this was because of a lack of trust in the vaccines. There were various myths surrounding vaccines in this part of the world, including getting infected with diseases from taking the vaccine, life-threatening side effects from the vaccine, and birth control plots by the west.

However, she pointed out that BCG vaccine coverage in Nigeria is commendable. Its initial low uptake was not completely linked to hesitancy but to parents' access to health facilities for their infants' BCG vaccination. Thus, while the availability of a new TB vaccine will be welcome in Nigeria, easy access to the new vaccine will effectively combat hesitancy.

Mercy further observed that generally this would not be an issue as the government agency responsible for the expanded programme on immunisation has some mechanism to deal with it. A massive vaccination campaign has addressed this for all childhood vaccinations, including BCG. There was some house-to-house vaccination of children eligible for BCG vaccine. Also, the eventual lifting of movement restrictions imposed due to COVID-19 has increased and improved access to health facilities for parents of infants.

Among the people who administer BCG vaccines in India are frontline community health workers or ASHA (Accredited Social Health Activist) workers. We spoke with Reshma Adagale, who is an ASHA worker in Maharashtra state of India and a part of Nagpur Municipal Corporation Employees Union: “During the 6-7 years of my working as ASHA worker, I have not had to convince much, as most people know it is important for children to get BCG vaccination and they are willing to get their babies vaccinated.

Very few (around 1-2%) need to be counselled about its benefits or any hesitation they may have. They may need to be informed about its public health benefits, about possible side effects, etc. Some people make flimsy excuses for not getting their child vaccinated, like ‘when children get injection they keep crying for a long time; or kids get fever after vaccination and then parents have to leave their work and take the kid to the hospital (which results in loss of wages)’; or that ‘we will get our child vaccinated if the family elders permit us to do so’; or ‘we did not get this vaccine in the past , so why should our child get it’.

These are some myths and misconceptions we come across at times. We try our best to convince them and get their kids vaccinated.” However, she confirmed that she had to work hard with people to counter vaccine hesitancy against COVID-19 vaccine.

Bhagyashree, another ASHA worker in Nagpur, India, told us that in the past 5 years of her work life, she has not encountered any vaccine hesitancy against BCG. Like Reshma, she said that COVID-19 vaccine hesitancy was there. “I had to convince them on vaccine benefits, educate them on side effects, and bust myths and misconceptions like ‘it will make us impotent’ etc, and eventually we got our whole area vaccinated against COVID-19.”

“We need to recognize the role of Auxiliary Nurse Midwives (ANMs) and ASHA workers who have been going door-to-door around the villages in raising awareness and health education about importance of these vaccines and other health interventions since years. Ultimately it is about involvement of healthcare workers and health literacy in the field. People may not know what is ‘BCG,’ but they are likely to understand that its shot will help protect their child from disease in future. Role of healthcare workers on the ground is phenomenal,” said Jibin TC, National Working Secretary of United Nurses Association.

Looking back over BCG vaccine rollout in the last 102 years

In May 1948, Indian Government had issued a press note stating that TB was “assuming epidemic proportions,” and that it had “after careful consideration” decided to introduce BCG vaccination. Government-run BCG Vaccine Laboratory was set up in Chennai, India, in 1948, which continues to produce this vaccine till to date.

BCG vaccine was introduced and has been used in Nigeria since 1921. However, in India the first BCG shots were given in August 1948. Later when India’s National TB Control Programme (now called the National TB Elimination Programme) began in 1962, BCG vaccination became its part.

Since there were questions on efficacy of BCG vaccine in preventing TB of the lungs from the early days, a large BCG clinical trial (Feasibility Study for TB Prevention Trial) was conducted in Chingelput, Tamil Nadu, India, during 1968-1987. This study showed that BCG vaccination did not offer significant protection against TB of the lungs which occurs mostly in adults.

That is why BCG vaccination policy was revised in India, recommending BCG vaccine to be given to young children within first year of the birth, by integrating it under Universal Immunization Programme. Other countries tweaked their BCG vaccine policy too due to the study’s findings. BCG is now given to infants soon after birth or later, but preferably before exposure to persons with active TB disease. The same is the practice in Nigeria, where the BCG vaccine is given within the first week of birth.

Ripple effect of becoming smallpox free

In 1958, World Health Assembly of the WHO, had passed a resolution to eradicate smallpox, following which India started its National Smallpox Eradication Programme in 1962 with the goal to give smallpox jab to all population. But the uptake of this vaccine (which was discovered in 1778) remained low in the following years for myriad reasons.

India eventually became smallpox free in 1977 and Nigeria in 1980. It is important to note that in India the first smallpox vaccine shot was administered in 1802. But it took almost 200 years to make India smallpox free in 1977.

After achieving its ‘smallpox-free’ milestone, India launched a nationwide Expanded Programme of Immunization in 1978 which included the goal to vaccinate 80% of infants in major urban hospitals with BCG vaccine. As was expected, coverage remained abysmally low. In 1985, India’s Expanded Programme of Immunization evolved as Universal Immunization Programme with major changes and a broader scope.

After about five decades of its setup, it was only in 2000-2001, when Indian government’s BCG Vaccine Laboratory was producing enough BCG vaccines to meet 100% requirement of Universal Immunization Programme, as well as to export the vaccine to other nations in need. Consequently, it stopped import of BCG vaccine. Private BCG manufacturers, including Serum Institute of India, began BCG vaccine production in 2002 onwards.

Will hesitancy be a barrier if a new TB vaccine is proven safe and effective?

“Current BCG coverage is high in most parts of India. If there are better vaccines people will take it - if its safety and efficacy is not in doubt. That is because a general idea that ‘vaccines are good for infants’ is accepted. But when we talk about vaccines for adults and/or older children (more than one year of age), then there are a whole lot of reasons why people may not want to opt for it,” said Dr Jacob John. “Reluctance in some people to take adult vaccination or get older children vaccinated is more of a sociological issue than hesitancy.”

We spoke to some leaders who are major influencers of TB response in India. “The existing BCG vaccine is a part of the universal immunization programme and is given to all infants born on day-zero. But the new vaccines that are being researched will hopefully be applicable to a larger population, if proven to be safe and effective. Research is currently underway so we will hopefully get to know soon if these new TB-vaccine candidates under research will be prioritised for most-at-risk populations, household contacts of TB patients, and for re-vaccination of those who got BCG shots earlier. The last word on the new vaccine(s) is not yet out to be used on a programmatic scale,” said Dr Kuldeep Singh Sachdeva, former head of India’s national TB programme who has been deeply involved in the fight against TB for around two decades now. He currently heads the Southeast Asia regional office of International Union Against Tuberculosis and Lung Disease (The Union).

There are several new TB vaccine candidates that are currently under different stages of research. Dr C Padmapriyadarsini, who is a noted scientist and the Director of government-run National Institute for Research in Tuberculosis. (NIRT), Indian Council of Medical Research, said: “NIRT is involved with the study of recombinant BCG vaccine, which is a TB preventive (prophylaxis) vaccine meant for the household contacts of TB patients. This study has been going on for almost 3 years now and is being done at 12 sites across India. In the study, household contacts of TB patients (who are above 14 years of age) were screened for TB and those who tested negative for TB disease, were given this TB preventive vaccine. There was a follow up period of 2 years to see whether they developed (or not developed) TB. While we are expecting good results, the interim results will be available by end of March 2023 or early April 2023. Only then will it be known if this vaccine is helpful in preventing TB.”

The recombinant BCG vaccine is also being tested in Bangladesh (and a few centres in India) to see if it can prevent TB recurrence when given to treated TB patients. Results of this are also expected around end of March 2023 or early April 2023.

India is also planning a study to investigate BCG revaccination or BCG vaccination in adult population. “We will investigate whether the BCG vaccine (that is currently used to vaccinate infants) can be used for adult vaccination to prevent TB. Some countries are already trying this BCG vaccine in adults to see whether it would prevent TB. A few small studies have shown that it increases the immunity of an individual,” said Dr Padmapriyadarsini.

“There could be hesitancy when a new TB vaccine is introduced. And to overcome that and increase its acceptance we need to create awareness in the public. We saw a similar thing in COVID-19 vaccine where initially there was a lot of hesitancy. So, we must create awareness in the public that the vaccine is safe, and from what does it protect. That type of confidence building will go a long way in removing vaccine hesitancy and increase uptake of any vaccine,” rightly said Dr Padmapriyadarsini.

Currently, feasibility and acceptability studies are also going on regarding the possible new TB vaccine in India, to find out if and why people might be hesitant to take it. “By the time the vaccine is ready we will have these results also. It would help if the vaccine became a part of the government vaccine immunization programme. For faster uptake, vaccine rollout must be a joint venture involving the manufacturer, government, public and private sector, and all other stakeholders who can help,” said Dr Padmapriyadarsini.

Dr Sachdeva agrees: “We will have to take along other stakeholders to help improve the acceptance of a possible new TB vaccine (currently under research) and scale up its uptake in the targeted populations. An important element for the roll out of new TB vaccine will be capacity building of the healthcare providers and the community. Lessons learned from COVID-19 vaccination will go a long way to reduce vaccine hesitancy to a large extent in the rollout of any new vaccine for TB or any other disease in the future.”

Not only was the TB programme adversely impacted due to the COVID-19 pandemic, but there was also a decline of TB funding from US$ 5.8 billion to US$ 5.3 billion, which resulted in a drop in the number of children who got BCG shots.

If we are to end TB, we must stop neglecting TB prevention – be it infection control or other measures that reduce risk of getting active TB disease. A safe and effective TB vaccine for all age groups is an important cog-in-the-wheel of the TB combination prevention cascade.

* Ode Uduu, Shobha Shukla, Bobby Ramakant wrote this article for
Ode Uduu is a Data Journalist with DataPhyte in Nigeria, and Shobha Shukla and Bobby Ramakant are part of the editorial team of CNS (Citizen News Service) in India.
Ode, Shobha and Bobby are among the Fellows of inaugural Public Health Reporting Corps in India and Nigeria facilitated by Population Reference Bureau – PRB.
Follow them on Twitter: @UduuOde, @Shobha1Shukla, @BobbyRamakant
This article was webcasted on March 24 2023.

* Comments posted by users in this discussion thread and other parts of this site are opinions of the individuals posting them (whose user ID is displayed alongside) and not the views of We strongly recommend that users exercise responsibility, sensitivity and caution over language while writing your opinions which will be seen and read by other users. Please read a complete Guideline on using comments on this website.

  • Violence in Manipur 2023 :: News Timeline
  • Violence unlikely to cease
  • Landscape: Phuba Thapham Village : Gallery
  • Alleged commencement of genocide campaign
  • World Environment Day 2023
  • Poppy plantation & narco terrorism
  • How to become a cyber security expert
  • No end in sight to violence
  • Time to validate reservation in health sector
  • Women CSOs meet Amit Shah : Gallery
  • Who is the Troublemaker in Manipur ?
  • Global Manipur Federation Established
  • Amit Shah Ji made it very clear
  • Beekeeping for a successful sweet revolution
  • Upward tick of body bags
  • Beginning of Life in the UK #5
  • Joseph's Son Premiere @Shanghai Film Fest
  • Memorandum to Union Home Minister
  • India's Act East Policy and its Influence on NE
  • Amit Shah plans to bring violence to an end
  • Women in civil services (Administrative)
  • High expectation, minimal crisis measures
  • A Voice From Khurkhul
  • Has appeasement towards Kuki backfired ?
  • Roaring through the Frontier
  • 3rd June is World Bicycle Day
  • Witnessing the resurgence
  • Setting the narratives right
  • Pinning hope on judicial probe to end crisis
  • Human-chain @ Keishampat #1 : Gallery
  • Wanted : The Idea of Manipur
  • Post of DGP Manipur
  • Fallout a legacy of colonial British rule #2
  • Workshop: Integration of Communication
  • Union Home Minister's visit is a step too late
  • Manipur in flames since one month
  • Random use of firearms debunks communal
  • Amit Shah visit to Manipur [31 May] : Gallery
  • Fallout a legacy of colonial British rule #1
  • Day 3 report of Amit Shah's visit
  • 8000 surrender since 2014; Manipur burning
  • Breast Cancer! What all you need to know
  • No magic formula spelt out
  • Armed attacks corroborate irrelevance of ST
  • Singju Fest @Heingang #2 : Gallery
  • June Calendar for Year 2023 : Tools
  • Memorandum to Union Home Minister
  • Condemned Vandal, Media Misinformation
  • The voice of India's traditional handlooms
  • Amit Shah in town
  • Task cut out for Centre to prevent battle
  • A family of painters & their works
  • Peace first - Solution next
  • Concern over ongoing ethnic violence
  • Condemnation of Act by Armed Militants
  • Nation building through Jan Bhagidari
  • Playing the victim card
  • Internet ban serving no real purpose
  • Relief camp @ Khundrakpam #2 : Gallery
  • How Nehru accepted ... a religious head
  • Observation of present unrest in Manipur #2
  • When rage hijacks sanity
  • Why internationationalisation of education
  • A case of Nero fiddled while Rome burnt ?
  • Beginning of Life in the UK #4
  • The Good Old Days :: Poem
  • Status of Mithun farming in NE
  • Beauty essentials for your holiday
  • Chaudhary Charan: The Voice of Rural India
  • Manipur crisis on centre's menu, at last
  • Curfew : Night time in Imphal : Gallery
  • Manipur turmoil - Dynamics and misgivings
  • Debate on Art 371-C, new facet to violence
  • Sausage as a value added product
  • Gender & anti-corruption : G-20 Agenda
  • Waiting for the Union Home Minister
  • Insecurity among MLAs as violence continues
  • Advanced INA Headquarters, Moirang #2
  • Mt. Khangchendzonga and me
  • Awakening call to our leaders :: Poem
  • The unseen costs of Internet shutdown
  • An open letter to PM Narendra Modi
  • Best choice of career options after 12th Arts
  • Time to think for the children
  • Gunmen loose in foothill, military in city
  • Sit-in-Protest [21 May] : Gallery
  • Manipur situation mentioned at UN
  • Observation of present unrest in Manipur #1
  • Man, woman, sex, sexuality and the truth
  • Japanese koi fish: Farming in Manipur
  • Khurakki Eena Lai Saba
  • Time to tilt the balance
  • The Story of Leishemba : Fungga Wari #2
  • Press Meet at Dispur Press Club, Guwahati
  • Condemns assault on media by armed forces
  • What/who is tearing Manipur apart ?
  • The fast & ugly spread on social media
  • Separate admin call: Acceptable to the Nagas?
  • Task for men in uniform to restore peace
  • HSE 2023 Toppers :: Science
  • HSE 2023 Toppers :: Arts
  • HSE 2023 Toppers :: Commerce
  • Why should Meitei be included in ST list?
  • Books are our Best Friends
  • Forced peace not viable line
  • Expansionism agenda at play
  • Sit-in-Protest @ Ima Keithel : Gallery
  • International Tea Day : Jimli
  • CSO meet at Manipuri Basti, Guwahati
  • History - A New Perspective :: Poem
  • Posers to New Delhi and Imphal
  • Beginning of Life in the UK #3
  • Silent murmurs longing for answers
  • Perturbed about the future of Manipur
  • Take immediate action to bring normalcy
  • Can Myanmar-B'desh cooperate in disaster
  • Reopen national highways before it's too late
  • Tree's greatest strength lie in its roots
  • Press Conference at Press Club of India
  • Solidarity meet in support of women wrestlers
  • Management of Fall Armyworm
  • Benefit & drawback of Taka-Rupee exchange
  • Time to set right the narrative
  • Sit-in-Protest in Imphal : Gallery
  • Writer of 'CCpur da khundariba Meetei sing'
  • Landing in Sikkim, 1983
  • Request for lifting ban on Internet
  • Farm income through efficient farm mgmt #2
  • Condemns rape of a minor girl in Assam
  • SoO pact under scanner
  • Price of cooked up stories & hatred
  • Angamba & Samuel: Friendship beyond riot
  • Supreme Court ruling on Manipur High Court
  • Bijou Thangjam in Kannada film: Chilli Chicken
  • Do you want a "New Nagaland" ?
  • Our nurses, our future
  • Attempt to seize ancestral Meetei land
  • Significant stand of TNL
  • Relief camp @ Khundrakpam #1 : Gallery
  • Featured Front Page Photo 2023 #2: Gallery
  • Instigating violence for narrow political gain
  • Agri-Tourism: Approach to rural development
  • Manipur on the boil since May 3
  • Time for introspection on communal riot
  • Ground assessment to expose riot plotters
  • Relief camp @ Moirang #2 : Gallery
  • Appeal to people who are blocking highway
  • Plantation drive of medicinal plants
  • People spirit to help each other shone bright
  • Useful tips for healthy teeth & a happy smile
  • Suspension of internet
  • Violence subsides, tension persists
  • The Story of Leishemba : Fungga Wari #1
  • Mother's Day calls for Peace
  • Farm income through efficient farm mgmt #1
  • Nari Shakti : Empowering the Nation
  • From streets to political corridor
  • Onus on SF to justify normalcy claims
  • Beginning of Life in the UK #2
  • Impact of Internet Ban on Students
  • An open letter to citizens of Manipur
  • Help Rebuild Manipur
  • Nutrition garden for food security
  • Condemns lack of efforts by state govt
  • Curtain Story
  • Shirui Lily Fest 2022 #2 : Gallery
  • The only way forward is peaceful coexistence
  • Advancing Indo-Naga peace process
  • The courage to be 'yourself'
  • Mass culturing technique of nematode
  • 3 decades of Panchayati Raj Institutions
  • Blacking out stand of 10 MLAs
  • Need to present a strong case
  • Bye to cashless transactions for now
  • Accelerate probe into communal clash
  • Mithingai Amagi Meeshi @ Drama : Gallery
  • Fight to end corporate capture of healthcare
  • Mother to all :: Poem
  • International Nurses Day - 12 May
  • NPF condemns same sex Marriage: Azo
  • Commercialized artificial insemination in pig
  • Not all in designated camps
  • Relief camp @ Moirang #1 : Gallery
  • Mass gathering for peace & harmony at Pune
  • Sapiens: A Brief History of Humankind :: Rvw
  • 'Demographic threat' to indigenous inhabitant
  • Galvanising Swachh Bharat Abhiyan
  • Uneasy calm as state limps back to normalcy
  • Probe inevitable to expose mayhem instigator
  • Time to focus on rehabilitation
  • Spare women and children, medical
  • Kangkum Village in Kamjong : Gallery
  • Appeal to all the people of Manipur
  • Genesis of Manipur crisis
  • Of people and communities
  • Scholarship for civil service aspirants
  • Understanding IES/ISS Examinations
  • Catalyst & solutions to ethnic clashes
  • Appeal to restore normalcy in Manipur
  • We need groundwater in Manipur
  • Just a little courage for the word 'No'
  • Working journalist movement
  • To SC against HC directive
  • 'Peace Appeal' by Women of Northeast
  • Celebrities urge national media not to publish...
  • To our Brothers and Sisters in Manipur
  • Calling for peace and relief
  • Importance of post harvest technology
  • Watermelon a Summer fruit
  • From May 3, 1993 to the present
  • COVID-19 : Impact in Manipur :: News Timeline
  • Beginning of Life in the UK #1
  • Ishanou : Film recognised as World Classic
  • Meghalaya government launches helpline
  • Manipur & NE - PM's favourite on MKB
  • Comfort Zone and Days of Yore :: Poem
  • Singiri Kona, the solitude Narasimha Temple
  • Advanced INA Headquarters, Moirang #1
  • Candle light vigil at Delhi
  • Restore calm & prevent further escalation
  • Appeal to give up violence
  • Refrain from violence
  • How to go for quick revision for JEE Advanced
  • It is not Tribals Vs Meiteis
  • MANITEX @ Nilakuthi #5 : Gallery
  • Lui-ngai-ni@ Chandel #2 : Gallery
  • Khongjom Day @ Khebaching : Gallery
  • 100th Episode of 'Maan Ki Baat' : Gallery
  • Id-ul-Fitr @ Imphal #2 : Gallery
  • Mangka tour of Switzerland & France : Gallery
  • Houses @ Thalon, Tamenglong #2 : Gallery
  • Downloadable Manipuri Calendar for 2023